Sipuleucel-T and Ipilimumab for Advanced Prostate Cancer

Part of paid clinical trials in Marina del Rey, California.

Sponsor
Prostate Oncology Specialists, Inc.
Study ID
NCT01832870
Phase
PHASE1
Status
Completed

Conditions

Eligibility Criteria

Sex
MALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

This is a clinical trial designed to quantify the immune response and determine the tolerability and side effects of sipuleucel-T when given in combination with ipilimumab for patients with advanced prostate cancer.

Key Dates

Start date
Apr 30, 2013
Status verified
Aug 2017
Primary completion
Feb 29, 2016
Completion
Feb 29, 2016

Study Design

Enrollment
9 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Treatment
    Patients enrolled will receive the standard 3-dose treatment of sipuleucel-T, followed by treatment(s) of ipilimumab.

Primary Outcome Measure

Antigen-specific memory T cell response [ Time Frame: After last sipuleucel-T and last ipilimumab, and follow-up period, an expected average of 15 months ]

Locations (1)

FacilityCityStateZIPSite coordinators
Prostate Oncology Specialists, Inc.Marina del ReyCalifornia90292-

Find similar trials in Marina del Rey, CA

By condition
Prostate cancer
By specialty
OncologyProstate oncologyMen's healthUrology
By research site
Prostate Oncology Specialists, Inc.· Marina del Rey, CA

Related Studies